A phase II trial of adjuvant cisplatin and doxorubicin in Stage I epithelial ovarian cancer
- 31 December 1991
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 43 (3) , 203-205
- https://doi.org/10.1016/0090-8258(91)90020-6
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Adjuvant Therapy in Stage I and Stage II Epithelial Ovarian CancerNew England Journal of Medicine, 1990
- Chemotherapy Consisting of Cisplatin, Doxorubicin, and Cyclophosphamide as an Adjunct to Surgery in Stage Ic-II Epithelial Ovarian CarcinomaAmerican Journal of Clinical Oncology, 1989
- An initial analysis of preoperative serum CA 125 levels in patients with early stage ovarian carcinomaGynecologic Oncology, 1988
- Staging laparotomy in early epithelial ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1986
- Staging laparotomy in early ovarian cancerJAMA, 1983
- Improved chemotherapy for ovarian cancer with cis-diamminedichloroplatinum and adriamycinCancer, 1981
- The role of adjuvant therapy in Stage I ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1980